• Discovery of biotech to support development the Innovative medicines and promotion of strategic joint investment by pharmaceutical companies in biotech

- (role of Gateway) Deal Sourcing Open Innovation, Establishment of a continuous and efficient discovery system for high-quality pipelines

- (role of priming water) Capital Open Innovation, Leading a system that can make continuous capital investment in excellent pipelines

- (role of platform) Development Open Innovation, Establishment of a flexible collaboration system that can supplement the necessary development capabilities

• Operation of KIMCo investment business

- Investment process : 1st Evaluation(written) ▷ 2nd Evaluation(IR Announcement) ▷ Review

- Investment Evaluation certeria : Evaluate the Market attractiveness ( scalability), Technology attractiveness (innovation/differentiation), Commercialization competitiveness (competitive advantage

- Investment schedule : Twice a year in the first half/second half

• Provision of investment plans for excellent biotech to participating companies, acceleration of practical collaboration between pharmaceutical companies and biotech

• Sharing future trends and insights through analysis of biopharmaceutical industry experts (technology, investment, etc.) and global industry data

※ KIMCo Talk(On·offline seminars), KIMCo Insight(Reports on the latest trends and issues related to technology, market, investment, etc.), KIMCo workshop etc

• Establishment of a collaboration platform and network that can complement each other's expertise required for new drug development and global commercialization

• Reinforcement of two-way communication with KIMCo-participating companies promotion of industry·university·government·pension·finance networking

• We have performed 'Project on developing TBM'(2021~2024) to support 7 pharmaceutical companies with a project cost of 13 billion won.

Promoting the global commercialization of TBM dominating the pharmerging market

• Publication of a market and technology analysis report to support companies participating in specific tasks to advance into the pharmerging market

• licensing consulting support, and operation of industry-academia consultative groups ∙

• KIMCo carried out '2023 QbD system roll-out supporting project' to conduct QbD consultation and operate a training program for QbD experts

Improving drug quality, Increasing the efficiency of R&D and manufacturing process, and creating the competitiveness in the global market

• Performed '2023 QbD system roll-out supporting project'

- [Consultation] Conducted at least 5 cases of customized consultation

- [Education] Operated training program for QbD experts

• KIMCo carried out '23 Smart Factory Setting Up Projects' for the sake of drug quality improvement

Increasing the efficiency of Manufacturing&Production&Quality Controls and the competitiveness of companies

• To inspect and manage projects so that the projects can be completed successfully

• Ministry of Trade, Industry and Energy 'mRNA vaccine raw material production advancement technology development'project ('22~'25) Joint implementation of overall project, KRW 18.1 billion supported to 5 pharmaceutical companies

Success in localization of production of cGMP-level core mRNA vaccine raw materials and securing global competitiveness

• mRNA vaccine raw material market/technology trend research, government/institutional/private (demand-supplier) consultative body operation, win-win cooperation between demand-supply companies and support for establishing an ecosystem for the vaccine industry, etc.